Gilead Pledges HIV Prevention Drug for Low-Income Nations Amid Funding Concerns

Published 2 days agoGILD

Gilead Pledges HIV Prevention Drug for Low-Income Nations Amid Funding Concerns

Gilead Sciences has confirmed its dedication to delivering lenacapavir, an innovative HIV prevention injection, to low-income countries even though funding remains uncertain. Lenacapavir has shown almost 100% efficacy in clinical trials and is anticipated to secure FDA approval by June 19, 2025. With the backing of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund, the drug is slated for rollout by early 2026, Reuters reported.

To enhance accessibility, Gilead plans to offer lenacapavir at production cost for two to three years, aiming for a pricing point between $100 and $120 annually in these countries. Despite this commitment, challenges loiter due to potential funding reductions in U.S. international aid, including PEPFAR. Organizations such as the Global Fund are attempting to rally the necessary support, yet the threat of funding cuts persists.

To further facilitate global access, Gilead has partnered with six generic manufacturers through royalty-free licensing agreements. This move is set to broaden the availability of lenacapavir across 120 low- and middle-income countries. However, the long-term success of these efforts is contingent upon securing consistent global funding and collaboration.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Delta Air Lines CEO Projects Surge in Travel Demand

Delta Air Lines CEO Projects Surge in Travel Demand

22 minutes agoDAL

Delta Air Lines is gearing up for a robust return in travel demand after experiencing a slowdown earlier this year. CEO Ed Bastian highlighted that consumers are prioritizing travel above other expenditures, suggesting solid demand for air travel. This resurgence is pivotal as the industry rebounds from recent challenges. The airline is setting its sights on 2025 as potentially the most profitable year in its century-long history, driven by a surge in demand for premium travel and stronger pricing strategies. Reuters reported that revenue from premium seats is outpacing main-cabin sales, bolstering Delta’s position as a leading premium carrier. Delta’s confidence is also underpinned by a resilient economy, with consumers increasingly seeking luxury experiences. Bastian’s optimism is echoed by industry analysts who are positive about the future of U.S. airlines, citing disciplined capacity management and solid consumer spending on experiences as key factors supporting this outlook.

AMD Gains Analyst Confidence with Strong Q4 Results and Product Advances

AMD Gains Analyst Confidence with Strong Q4 Results and Product Advances

Advanced Micro Devices (AMD) is receiving upbeat assessments from analysts following an impressive financial performance in the fourth quarter. Citi upgraded AMD to a 'Buy' rating, setting a price target of $136, crediting the company's successful AI product launches and improved profit margins. Meanwhile, Barclays raised their evaluation to 'Overweight' with a price target of $85, noting AMD's competitive position in the server market through its new data center product, Genoa. Jefferies also expressed optimism, increasing their price target to $200 while maintaining a 'Buy' status due to AMD's promising data center AI market penetration, as reported by TheStreet.com. For the fourth quarter, AMD reported earnings of 77 cents per share—an 11.5% growth over the prior year—meeting Wall Street's expectations. The company’s revenue rose by 10.1%, reaching $6.17 billion, slightly surpassing analyst forecasts. This solid financial footing supports AMD’s strategic thrust into AI and data centers, which has been met positively by stock analysts, according to TheStreet.com. Looking ahead, AMD appears poised for continued influence in the AI GPU sector, with some analysts suggesting the potential to exceed expectations by 2025, highlighted by PowerStocks.io. Despite facing intense competition, AMD is noted for its growth in server compute and PC sales, contributing to the momentum it's building within the semiconductor industry.

Tariff Exemptions Boost Apple's Market Position

Tariff Exemptions Boost Apple's Market Position

2 hours agoAAPL

The U.S. government has recently granted tariff exemptions for smartphones, a decision that significantly benefits Apple by preventing cost hikes and preserving its competitive edge in pricing. Reuters noted that this exemption is particularly advantageous for Apple in maintaining its market position amidst ongoing trade policy challenges. Apple continues to bolster its resilience to tariff impacts by diversifying its manufacturing operations, particularly through increasing production in India. This strategic move allows the company to more effectively adjust its supply chain in response to fluctuating trade policies, reported TheStreet.com. Analysts from Bank of America have deemed the potential tariff impacts on Apple's earnings as manageable. They believe that Apple can navigate these challenges through strategic pricing and supply chain optimizations. Furthermore, the recent tariff exemptions have led to some analysts upgrading Apple’s stock rating, suggesting a more positive outlook in light of these developments.

NIO Inc. Reports Strong Vehicle Deliveries in May 2025

NIO Inc. Reports Strong Vehicle Deliveries in May 2025

NIO Inc. announced it delivered an impressive 23,231 vehicles in May 2025, marking a significant achievement for the electric vehicle maker. This milestone reflects a substantial 53% increase from May 2024, signaling robust demand and production capabilities. In terms of brand contributions, 19,269 of these were from the NIO brand, while their ONVO brand accounted for 4,400 vehicles. NIO's cumulative deliveries have now reached a total of 760,789 vehicles as of May 31, 2025. The company also recently began delivering a new model under its Firefly brand, a small smart high-end electric car that debuted in late April 2025. Despite these strong delivery numbers, NIO's stock performance showed a slight decrease. As reported by Reuters, the current share price stands at $3.54, down by $0.14, which translates to a 0.04% decline from its previous close. The stock's intraday movement saw a high of $3.65 and a low of $3.52, reflecting ongoing market fluctuations.